Cargando…
Selegiline remarkably improved stage 5 treatment-resistant major depressive disorder: a case report
We report a case in which selegiline, an irreversible monoamine oxidase B (MAO-B) inhibitor, greatly improved depressive symptoms in an adult with stage 5 treatment-resistant major depressive disorder. Four antidepressants and four augmentation therapies had previously been ineffective or intolerabl...
Autores principales: | Kitaichi, Yuji, Inoue, Takeshi, Mitsui, Nobuyuki, Nakagawa, Shin, Kameyama, Rie, Hayashishita, Yoshiyuki, Shiga, Tohru, Kusumi, Ichiro, Koyama, Tsukasa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3804584/ https://www.ncbi.nlm.nih.gov/pubmed/24204150 http://dx.doi.org/10.2147/NDT.S49261 |
Ejemplares similares
-
Effect of triiodothyronine (T(3)) augmentation of acute milnacipran administration on monoamine levels: an in vivo microdialysis study in rats
por: Kitaichi, Yuji, et al.
Publicado: (2012) -
Association between suicide-related ideations and affective temperaments in the Japanese general adult population
por: Mitsui, Nobuyuki, et al.
Publicado: (2017) -
Effect of the coadministration of citalopram with mirtazapine or atipamezole on rat contextual conditioned fear
por: Masuda, Takahiro, et al.
Publicado: (2014) -
Confirmation of the factorial structure of the Japanese short version of the TEMPS-A in psychiatric patients and general adults
por: Nakato, Yasuya, et al.
Publicado: (2016) -
The structural equation analysis of childhood abuse, adult stressful life events, and temperaments in major depressive disorders and their influence on refractoriness
por: Toda, Hiroyuki, et al.
Publicado: (2015)